预防和治疗胎儿生长受限的核心结局集:开发终点指标——COSGROVE研究
本研究为德尔菲共识研究,旨在为胎儿生长受限的预防或治疗试验制定核心结局集。通过文献综述和3轮在线德尔菲调查(135名医疗提供者、68名研究者/学者、35名公众),最终共识会议(5名医疗提供者、5名研究者/学者、6名孕产服务使用者)确定了22个结局,分属母体(4个)、胎儿(1个)、新生儿(12个)和儿童期(5个)4个领域。
要点
- 最终核心结局集包含22个结局,分属母体、胎儿、新生儿和儿童期4个领域。
- 共识通过3轮在线德尔菲调查和一次面对面会议达成。
- 该核心结局集旨在使未来胎儿生长受限预防或治疗试验测量并报告相似的有意义结局。
核心结论
- COSGROVE研究识别了大量潜在相关结局,并就未来所有胎儿生长受限预防或治疗试验至少应测量和报告的结局达成共识。
研究设计与样本
- 本研究为德尔菲共识研究,通过文献综述识别结局,并开展3轮在线德尔菲调查(135名医疗提供者、68名研究者/学者、35名公众)进行优先级排序,最终面对面会议(5名医疗提供者、5名研究者/学者、6名孕产服务使用者)依据预先设定的共识标准达成最终核心结局集。
主要发现
- 最终核心结局集共纳入22个结局,分属4个领域:母体(n=4)、胎儿(n=1)、新生儿(n=12)和儿童期(n=5)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fetal growth restriction refers to a fetus that does not reach its genetically predetermined growth potential. It is well-recognized that growth-restricted fetuses are at increased risk of both short- and long-term adverse outcomes. Systematic evaluation of the evidence from clinical trials of fetal growth restriction is often difficult because of variation in the outcomes that are measured and reported. The development of core outcome sets for fetal growth restriction studies would enable future trials to measure similar meaningful outcomes. OBJECTIVE: The purpose of this study was to develop core outcome sets for trials of prevention or treatment of fetal growth restriction. STUDY DESIGN: This was a Delphi consensus study. A comprehensive literature review was conducted to identify outcomes that were reported in studies of prevention or treatment of fetal growth restriction. All outcomes were presented for prioritization to key stakeholders (135 healthcare providers, 68 researchers/academics, and 35 members of the public) in 3 rounds of online Delphi surveys. A priori consensus criteria were used to reach agreement on the final outcomes for inclusion in the core outcome set at a face-to-face meeting with 5 healthcare providers, 5 researchers/academics, and 6 maternity service users. RESULTS: In total, 22 outcomes were included in the final core outcome set. These outcomes were grouped under 4 domains: maternal (n=4), fetal (n=1), neonatal (n=12), and childhood (n=5). CONCLUSION: The Core Outcome Set for the prevention and treatment of fetal GROwth restriction: deVeloping Endpoints study identified a large number of potentially relevant outcomes and then reached consensus on those factors that, as a minimum, should be measured and reported in all future trials of prevention or treatment of fetal growth restriction. This will enable future trials to measure similar meaningful outcomes and to ensure that findings from different studies can be compared and combined.
引用
- Healy P, Gordijn SJ, Ganzevoort W, et al. A Core Outcome Set for the prevention and treatment of fetal GROwth restriction: deVeloping Endpoints: the COSGROVE study. Am J Obstet Gynecol. 2019. PMID: 31152710. doi:10.1016/j.ajog.2019.05.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。